These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15751199)

  • 1. FDA issues public health advisory recommending limited use of COX-2 inhibitors.
    S Afr Med J; 2005 Feb; 95(2):92. PubMed ID: 15751199
    [No Abstract]   [Full Text] [Related]  

  • 2. Merck withdraws Vioxx; FDA issues public health advisory.
    FDA Consum; 2004; 38(6):11. PubMed ID: 15675020
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug safety. FDA panel urges caution on many anti-inflammatory drugs.
    Couzin J
    Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA warns Merck over its promotion of rofecoxib.
    Josefson D
    BMJ; 2001 Oct; 323(7316):767. PubMed ID: 11588068
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alleviating pain and preventing inflammation with selective COX-2 inhibitors. Prescribing with confidence in the future].
    MMW Fortschr Med; 2005 Mar; 147(9):12. PubMed ID: 15794346
    [No Abstract]   [Full Text] [Related]  

  • 6. What is a 'safe' drug?
    Healy B
    US News World Rep; 2004 Dec; 137(21):37. PubMed ID: 15636504
    [No Abstract]   [Full Text] [Related]  

  • 7. COX-2 inhibitors--lessons in drug safety.
    Psaty BM; Furberg CD
    N Engl J Med; 2005 Mar; 352(11):1133-5. PubMed ID: 15713946
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke.
    Lenzer J
    BMJ; 2005 Feb; 330(7489):440. PubMed ID: 15731142
    [No Abstract]   [Full Text] [Related]  

  • 9. A lost opportunity for public health--the FDA advisory committee report on menthol.
    Siegel M
    N Engl J Med; 2011 Jun; 364(23):2177-9. PubMed ID: 21542736
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA labors over NSAID decisions: panel suggests COX-2 inhibitors stay available.
    Young D
    Am J Health Syst Pharm; 2005 Apr; 62(7):668-72. PubMed ID: 15790792
    [No Abstract]   [Full Text] [Related]  

  • 11. Rofecoxib, Merck, and the FDA.
    Wolfe MM
    N Engl J Med; 2004 Dec; 351(27):2875-8; author reply 2875-8. PubMed ID: 15625749
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA issues public health advisory on phenylpropanolamine in drug products.
    Meadows M
    FDA Consum; 2001; 35(1):9. PubMed ID: 11930934
    [No Abstract]   [Full Text] [Related]  

  • 13. COX-2 selective drugs and cardiovascular risks: same data but discrepant conclusions?
    Bannwarth B
    Expert Opin Drug Saf; 2006 Jan; 5(1):1-2; author reply 1-2. PubMed ID: 16370948
    [No Abstract]   [Full Text] [Related]  

  • 14. [The rise and fall of Vioxx: society, values and their choice].
    Caspi D
    Harefuah; 2004 Nov; 143(11):770-1. PubMed ID: 15603261
    [No Abstract]   [Full Text] [Related]  

  • 15. Raising the safety bar--the FDA's coxib meeting.
    Okie S
    N Engl J Med; 2005 Mar; 352(13):1283-5. PubMed ID: 15800221
    [No Abstract]   [Full Text] [Related]  

  • 16. New COX-2 arthritis drug receives FDA approval.
    J Gend Specif Med; 2002; 5(2):6. PubMed ID: 11974679
    [No Abstract]   [Full Text] [Related]  

  • 17. Failing the public health--rofecoxib, Merck, and the FDA.
    Topol EJ
    N Engl J Med; 2004 Oct; 351(17):1707-9. PubMed ID: 15470193
    [No Abstract]   [Full Text] [Related]  

  • 18. Hard times at the FDA.
    Nat Immunol; 2005 Feb; 6(2):115. PubMed ID: 15662433
    [No Abstract]   [Full Text] [Related]  

  • 19. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
    Vanchieri C
    J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872
    [No Abstract]   [Full Text] [Related]  

  • 20. New use approved for Vioxx.
    FDA Consum; 2002; 36(4):3. PubMed ID: 12184302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.